The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in pancreatic adenocarcinoma (PDA) patients (pts) with genetic alterations in DNA damage repair (DDR) pathways: Results from the Know Your Tumor (KYT) program.
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Caris Life Sciences; Celgene; Merrimack; Sirtex Medical
Consulting or Advisory Role - ARMO BioSciences; AstraZeneca/MedImmune; Caris Life Sciences; Celgene; Ignyta; Perthera; Rafael Pharmaceuticals; RenovoRx; Sirtex Medical
Research Funding - ARMO BioSciences (Inst); Bavarian Nordic (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Curegenix (Inst); FibroGen (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Caris Life Sciences; Perthera; Sirtex Medical
 
Edik Matthew Blais
Employment - Perthera
 
Jonathan Robert Brody
Consulting or Advisory Role - Perthera
Travel, Accommodations, Expenses - Perthera
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - Perthera
Research Funding - Agios (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Novartis (Inst); OncoMed (Inst)
Travel, Accommodations, Expenses - Foundation Medicine
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Ipsen; Novartis; Perthera; Xbiotech
Travel, Accommodations, Expenses - Halozyme
 
Vincent Chung
Consulting or Advisory Role - Celgene; Five Prime Therapeutics; Ipsen; Perthera
Speakers' Bureau - Celgene
 
Sameh Mikhail
Consulting or Advisory Role - HERON; Lilly
 
Lola Rahib
No Relationships to Disclose
 
Emily Lyons
No Relationships to Disclose
 
Lisa Tibbetts
Employment - Perthera
 
Subha Madhavan
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
Consulting or Advisory Role - Perthera
Research Funding - Teewinot Life Sciences (Inst)
 
Lynn McCormick Matrisian
No Relationships to Disclose
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Avant Diagnostics; Ceres Nanosciences; Perthera
Consulting or Advisory Role - Avant Diagnostics; AZGen; Ceres Nanosciences; Perthera
Research Funding - Abbvie (Inst); Ceres Nanosciences (Inst); GlaxoSmithKline (Inst); Symphogen (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera